Quick thoughts - pros and cons Few things I don't like:
Page 22 & 23 of MD&A - Decent amount of money going to companies that insiders are involved with. Also concentration risk on page 22 is interesting . I think they are terminating Marley natural deal in Washington and writing down the IP / license to nil (page 9-10 md&a)
For the year - an increase of 16 mill for operating expenses. 9 765 800 to
25 948 899 (page 17MD&A) . An 8 mill increase year over year for salaries benefits and consulting fees. One weird thing - 1 mill destruction of raw material and raw products (page 18 md&a)
Cogs for pasa verde and Oregon are higher than sales but not by much . .
what I do like.. they are selling product . 5 mill + a quarter / 23 408 630 from Calyx (cogs are high 17 872 915) Sounds like Fli Labs NorCal might be online in spring 2020.. (MD&A)
not excited about liabilities .
nevada is a waiting game . Still need to make a payment of a couple mill .
. My current take - not too surprised in a bad way or a good way . Kind of same as last quarter except I don't think we had as much of a loss . Company is still experiencing growing pains and the acquisition of calyx etc is still relatively new , has grown rapidly since the acquisition and is situated in key area in Cali where around 1000-2000 new dispensaries are set to open.
also no idea about "notice of meeting and record date"
would love to hear other opinions and thoughts about yearly fins and info in md&a...
will have to re visit tomorrow with fresh eyes and potentially a more cheery disposition. Apologies for all venting and bad jokes.
someone lend me those rose goggles .
cheers all .